AnaCardio
About:
AnaCardio is a clinical stage biopharmaceutical company developing novel drugs to treat heart failure.
Website: https://anacardio.com
Top Investors: Industrifonden, Flerie Invest, Karolinska, 3B Ventures, Nybohov Invest
Description:
AnaCardio is a clinical stage biopharmaceutical company developing novel drugs to treat heart failure.
Total Funding Amount:
183M SEK
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Solna, Stockholms Lan, Sweden
Founded Date:
2017-01-01
Founders:
Number of Employees:
1-10
Last Funding Date:
2022-09-07
IPO Status:
Private
Industries:
© 2025 bioDAO.ai